What is the dose of Hepamerz (hepatoprotective agent) sachet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Hepamerz Dosage

There is no information available in the provided studies regarding the dose of Hepamerz (hepatoprotective agent) sachet.

Available Hepatoprotective Agents and Their Dosages

  • L-ornithine L-aspartate (LOLA) has been studied for its hepatoprotective properties, with a dose of 6-9 g/d showing a dose-related reduction in activities of liver enzymes and triglycerides 1
  • S-adenosylmethionine (AdoMet) has been studied for its protective effect in cancer chemotherapy-induced liver toxicity, with oral supplementation showing a significant reduction in AST, ALT, and LDH levels 2
  • Oleanolic acid (OA) has been shown to be hepatoprotective at low doses, but hepatotoxic at high doses, with the exact dose not specified in the study 3

Key Points

  • The dose of Hepamerz sachet is not mentioned in the provided studies
  • Other hepatoprotective agents have been studied, with varying dosages and effects
  • It is essential to consult the specific product label or medical professional for accurate dosage information 4, 5

References

3
Research

Oleanolic acid reprograms the liver to protect against hepatotoxicants, but is hepatotoxic at high doses.

Liver international : official journal of the International Association for the Study of the Liver, 2019

5
Research

Present status of hepatoprotectants.

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques, 1999

Related Questions

What are the guidelines for using Ambien (zolpidem) in patients with liver disease?
What antihistamine is recommended for patients with liver impairment?
What are the guidelines for using Apixaban (eliquis) in patients with liver dysfunction?
Are benzodiazepines (BZDs) safe to use in patients with cirrhosis?
How to safely manage a patient on multiple medications with potential drug interactions and elevated liver levels?
What causes a decrease in CD4 count in an HIV (Human Immunodeficiency Virus) patient?
What is the post-exposure prophylaxis (PEP) regimen for a needle stick injury?
Which statement is incorrect regarding Pneumocystis jirovecii pneumonia: increased serum Lactate Dehydrogenase (LDH), visible cysts on chest radiograph as pneumatoceles, rare exercise desaturation, Trimethoprim-Sulfamethoxazole (TMP-SMX) as treatment of choice, or involvement of liver, spleen, and lymph nodes?
What is the frequency of intravenous (IV) morphine administration?
When should Human Immunodeficiency Virus (HIV) post-exposure prophylaxis (PEP) be initiated?
What is the significance of heart rate in a Cardiac Computed Tomography (CT) scan?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question